Advanced B-Cell Acute Lymphoblastic Leukemia

The Advanced B-Cell Acute Lymphoblastic Leukemia (B-ALL), Cytogenetic Panel is a specialised test that examines the chromosomes of leukemia cells to identify genetic abnormalities associated with B-cell acute lymphoblastic leukemia. These chromosomal changes play a key role in confirming the diagnosis, classifying the disease, assessing prognosis, and guiding treatment decisions. Performed on bone marrow or peripheral blood samples, this panel provides valuable genetic information that complements flow cytometry, molecular testing, and routine microscopic examination.

Who Should Get This Test Done?

      This test may be recommended for:

●     Individuals with newly diagnosed or suspected B-cell acute lymphoblastic leukemia.

●     Individuals with abnormal blood counts or bone marrow findings suggestive of acute leukemia.

●     Individuals requiring cytogenetic analysis for disease classification and risk assessment.

●     Individuals whose healthcare provider is planning targeted or risk-adapted treatment.

●     Individuals undergoing a comprehensive diagnostic work-up or follow-up for B-ALL.

Why Consider This Test?

    This test:

●     Detects chromosomal abnormalities associated with B-cell acute lymphoblastic leukemia.

●     Helps confirm the diagnosis and accurately classify the disease.

●     Provides important prognostic information that supports treatment planning.

●     Identifies genetic changes that may influence therapeutic decisions.

●     Complements flow cytometry and molecular studies for a comprehensive leukemia evaluation.

More Information

The Advanced B-ALL Cytogenetic Panel evaluates the chromosomes of leukemia cells to identify structural and numerical abnormalities that are known to occur in B-cell acute lymphoblastic leukemia. These genetic findings help distinguish different subtypes of the disease and provide information about its biological behaviour. The results are interpreted together with clinical findings, complete blood counts, bone marrow examination, immunophenotyping, and molecular tests to provide a comprehensive assessment and guide patient management.

Other Names

●     Advanced B-Cell ALL Cytogenetic Panel

●     B-Cell Acute Lymphoblastic Leukemia Cytogenetic Analysis

●     B-ALL Chromosome Analysis

●     Cytogenetic Panel for B-Cell Acute Lymphoblastic Leukemia

●     B-ALL Karyotyping Panel